Date Published
Country
Source
Videos
close
-
Are Drug Prices Too High? Should QALYs Be Used to Measure a Drug's Value? And Should a Government Entity Be Making Price and Value Determinations? A Conversation with Dan Ollendorf.
Dan Ollendorf, Ph.D., M.P.H.,of the Center for the Evaluation of Value and Risk in Health at Tufts University Medical Center, is co-author of a new book, The Right Price, A Value-Based Prescription for Drug Costs. -
Steven D. Pearson Shares if PCSK9 Pricing Put ICER on Map
Steven D. Pearson, M.D., M.Sc., founder and president of ICER addresses if pricing of PCSK9 inhibitors put ICER on the map.Comments
No comments yet. Create an account and log in to post a comment.
-
Stephen Pearson of ICER Talks Access and Price of Cholesterol Agents
Can price affect access?
Comments
No comments yet. Create an account and log in to post a comment.
-
Steven Pearson of ICER Discusses a Drug's Effect on Disparities
Are a drug's effect on disparities factored into ICER assessments?Comments
No comments yet. Create an account and log in to post a comment.
-
Are Ultra-High Drug Prices Sustainable?
Discussion on high-priced drugs and whether the prices are sustainable in the long run.Comments
No comments yet. Create an account and log in to post a comment.
-
Minimum Wage Increase, Insulin Price Cap: New Laws Coming to Illinois in 2021
The arrival of 2021 brings with it few new laws in Illinois due to a shortened spring session of the General Assembly because of the COVID-19 pandemic.Comments
No comments yet. Create an account and log in to post a comment.
Comments